Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
International Journal of Pharmaceutics|May 27, 2017
Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassembliesCharles Skarbek, Julia Delahousse, Catherine Pioche-Durieu, et al.
Therapeutic Drug Monitoring|March 13, 2012
Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric cohort undergoing hematopoietic stem-cell transplantationAngelo Paci, Gilles Vassal, Despina Moshous, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2006
Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumorsAngelo Paci, Keyvan Rezai, Alain Deroussent, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2017
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomasJulia Delahousse, Loic Verlingue, Sophie Broutin, et al.
Endocrinology, Diabetes & Metabolism Case Reports|June 15, 2016
Dyslipidemia causes overestimation of plasma mitotane measurementsAngelo Paci, Ségolène Hescot, Atmane Seck, et al.
Cardiovascular and Interventional Radiology|February 23, 2018
Pickering-Emulsion for Liver Trans-Arterial Chemo-Embolization with OxaliplatinFrederic Deschamps, Kathleen R Harris, Laurence Moine, et al.
Pharmaceutical Research|April 20, 2016
Iron Overload Exacerbates Busulfan-Melphalan Toxicity Through a Pharmacodynamic Interaction in MiceJérôme Bouligand, Clémentine Richard, Dominique Valteau-Couanet, et al.
The Oncologist|February 8, 2021
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell CarcinomaElie Rassy, Luigi Cerbone, Edouard Auclin, et al.
Endocrine-Related Cancer|July 2, 2010
Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinomaPasqualino Malandrino, Abir Al Ghuzlan, Marine Castaing, et al.
European Journal of Cancer (Oxford, England : 1990)|July 28, 2017
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation studyEric Angevin, Philippe A Cassier, Antoine Italiano, et al.
Pageof 11